The European Investment Bank (EIB) and CureVac, a biopharmaceutical company developing innovative medicines based on optimized messenger ribonucleic acid (mRNA), entered into a €75 million loan...
Greetings all, and welcome to the latest update from EAPM, writes European Alliance for Personalised Medicine (EAPM) Executive Director Denis Horgan. First of all, a quick...
Greetings all, and please click here for EAPM’s monthly newsletter for July. Prior to tipping into that month, and the start of the German EU Presidency,...
Greetings, colleagues, and here’s the latest European Alliance for Personalised Medicine (EAPM update as we approach what we would normally call ‘summer’, writes EAPM Executive Director...
Welcome all, to the latest European Alliance for Personalised Medicine (EAPM) update, not surprisingly dominated by the coronavirus crisis. Before we give you the round-up, here’s...
Greeting, colleagues - on a day when it has been announced that global coronavirus infections have topped eight million, with COVID-19 now spreading fastest in Latin...
Greetings, colleagues, and welcome to another update from EAPM HQ as we move properly into the month of June, writes European Alliance for Personalised Medicine (EAPM)...